Review of UK’s R&D tax relief system: implications for life sciences
UK life sciences businesses routinely engage in overseas research initiatives and clinical trials to inform the development of new medicines. That activity could fall outside the scope of the UK tax reliefs system for research and development (R&D) under potential reforms the UK government is considering.
